| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ONDS | Warrants (right to buy) | Other | $0 | -2,374,208 | -100% | $0.000000* | 0 | 31 May 2024 | Common Stock | 2,374,208 | $0.8900 | Stage 1 Growth Fund LLC (Series WAVE, Class A) | F1, F2 |
| transaction | ONDS | Warrants (right to buy) | Other | $0 | -7,825,792 | -100% | $0.000000* | 0 | 31 May 2024 | Common Stock | 7,825,792 | $0.8900 | Stage 1 Growth Fund LLC (Series WAVE, Class A) | F2, F3 |
| transaction | ONDS | Warrants (right to buy) | Award | $0 | +3,864,542 | $0.000000 | 3,864,542 | 31 May 2024 | Common Stock | 3,864,542 | $0.8900 | Stage 1 Growth Fund LLC Series WAVE | F4 |
| Id | Content |
|---|---|
| F1 | Pursuant to an Assignment, dated May 31, 2024, Stage 1 Growth Fund LLC (Series WAVE, Class A) (the "SPV") assigned the warrant, dated August 11, 2023, to Stage 1 Growth Fund, LLC Series Wave (the "New SPV"). |
| F2 | CFO Fund GenPar, LLC, a Texas limited liability company ("CFO Fund"), is the Managing Member of Charles & Potomac Capital, LLC ("C&P"). The reporting person is the sole control person of CFO Fund and C&P. C&P is the proxy for the members of the SPV, and the manager of the SPV must act in accordance with C&P's direction with respect to exercise and voting of the issuer's securities and derivative securities held by the SPV. The reporting person is the sole control person of C&P. |
| F3 | Pursuant to an Assignment, dated May 31, 2024, the SPV assigned the warrant, dated July 21, 2023 (the "July Warrant"), to the New SPV. |
| F4 | Following the assignment of the July Warrant, C&P indirectly holds a warrant through the New SPV, to purchase 3,864,542 shares of common stock, par value $0.0001 per share, of the issuer. |